期刊文献+

RP-HPLC测定恩替卡韦钠片剂含量

RP-HPLC determination of entecavir sodium tablets
暂未订购
导出
摘要 目的:建立高效液相色谱法测定恩替卡韦钠片的含量。方法:采用 Capcell Park C_(18)色谱柱(4.6 mm×200 mm,5μm),以甲醇-水-三乙胺(20:80:0.1)为流动相,流速为1.0 mL·min^(-1),检测波长243 nm,柱温为室温。结果:恩替卡韦钠在3.0~200μg·mL^(-1)(r=0.9992,n=6)范围内呈良好的线性关系;最低检测限为0.01 ng;高、中、低3种不同浓度的平均回收率为100.1%~100.6%,精密度为0.48%。结论:本方法简便快速结果准确可靠,可用于该药物质量标准研究。 Objective :To establish a method for determination of entecavir sodium tablets. Method:A column of Capcell Park ClS (4.6mm×200mm,5μm) at room temperature,a mobile phase consisting of methanol -watertriethylamine (20: 80: 0. 1 ) with a flow rate of 1.0 mL· min^- 1, and a UV detector at 243 nm were adopted. Results: The linear range of the determination by RP - HPLC was 3.0 - 200μg·mL^ - 1. ( r = 0. 9992, n = 6 ) ; The least detective range was 0. 01 ng;The average recovery was from 100. 1% to 100. 6% with a precision of 0. 48% were obtained. Conclusion:A simple and accurate method is established for determination of entecavir sodium, and can be used for quality control of entecavir sodium tablets.
出处 《药物分析杂志》 CAS CSCD 北大核心 2007年第8期1267-1268,共2页 Chinese Journal of Pharmaceutical Analysis
关键词 恩替卡韦钠 高效液相色谱法 含量测定 entecavir sodium HPLC determination
  • 相关文献

参考文献3

  • 1YANG Xi-hong(杨喜鸿).Preparation and user of entecavir sodium(恩替卡韦钠及其制备方法和应用) P.CN:200510074418.8.
  • 2方玉春,杨喜鸿,刘为忠,朱伟明,顾谦群.恩替卡韦钠的核磁共振谱分析[J].波谱学杂志,2006,23(4):523-527. 被引量:1
  • 3Manns ME,Raptopoulou -Gigi M,Sollano J, et al. Entecavir is well tolerated for the treatment of nucleoside - naive and lamivudine - refractory chronic hepatitis B: Phase II/III safety results. J Hepatol, 2005,42(2) :185.

二级参考文献6

  • 1李英俊,刘素娜,靳焜,彭勤纪,孙淑琴,许永廷,王营.具有潜在抗菌活性的环丙沙星衍生物的NMR谱研究(英文)[J].波谱学杂志,2004,21(3):317-321. 被引量:8
  • 2Yang Xi-hong(杨喜鸿),Fang Yu-chun(方玉春).Preparation and application.of entecavir sodium(恩替卡韦纳及其制备和应用)[P].CN:200510074418.8,2005-05-23.
  • 3Manns M E,Raptopoulou M G,Sollano J,et al.Entecavir is well tolerated for the treatment of nucleoside-naive and lamivudine refractory chronic hepatitis B:Phase Ⅱ/Ⅲ safety results[J].J Hepatol,2005,42:185-213.
  • 4Bisacchi G S,Chao S T,Bachard C,et al.BMS-200475,a novel carboxylic 2,-deoxyguanosine analog with potent and selective anti-hepatitis B virus activity in vitro[J].Bioorg Med Chem Lett,1997,7:127-132.
  • 5Bisacchi G S.Improved process for preparing the antiviral agent[1S (1α,3α,4β)]-2-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-2 methylenecyclopentyl]-6H-purin 6-one[P].WO:98109964,1998-03-12.
  • 6李勤,杨春晖,刘雪辉,赵兴凯,崔育新.3种药物分子的~1H和^(13)C NMR谱线全指定[J].波谱学杂志,2004,21(2):221-229. 被引量:9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部